Abiomed (ABMD) Tops Q1 Views; Raises Outlook
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Other (expense) income, net: -114K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Other (expense) income, net: -114K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Abiomed (NASDAQ: ABMD) reported Q1 GAAP EPS of $1.95, which may not compare to the analyst estimate of $0.82. Revenue for the quarter came in at $180 million versus the consensus estimate of $173.27 million.
GUIDANCE:
Abiomed sees FY2019 revenue of $775-790 million, up %15 million versus prior view and the consensus of $768.1 million.
For earnings history and earnings-related data on Abiomed (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
- BWS Financial Downgrades Inter Parfums (IPAR) to Sell
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
